These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34753497)

  • 1. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies.
    Rolver MG; Emanuelsson F; Nordestgaard BG; Benn M
    Cardiovasc Diabetol; 2024 May; 23(1):165. PubMed ID: 38730445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.
    Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study.
    Mantovani A; Busti F; Borella N; Scoccia E; Pecoraro B; Sani E; Morandin R; Csermely A; Piasentin D; Grespan E; Castagna A; Bilson J; Byrne CD; Valenti L; Girelli D; Targher G
    Cardiovasc Diabetol; 2024 Aug; 23(1):305. PubMed ID: 39154180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effect of blood pressure and C-reactive protein with the risk of mortality from coronary heart and cardiovascular diseases.
    Kurl S; Jae SY; Voutilainen A; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2051-2057. PubMed ID: 34090772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
    Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
    J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes.
    Hoes LLF; Riksen NP; Geleijnse JM; de Groot MCH; T van der Schouw Y; Visseren FLJ; Koopal C;
    Diabetes Res Clin Pract; 2024 Jul; 213():111727. PubMed ID: 38848966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.
    Wang Z; Tang J; Shi Q; Fang L; Liu N; Zhang J
    Front Endocrinol (Lausanne); 2024; 15():1392859. PubMed ID: 38812817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2.
    Davis TME; Chubb SAP; Davis WA
    Cardiovasc Diabetol; 2024 Oct; 23(1):362. PubMed ID: 39402659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study.
    Gedebjerg A; Bjerre M; Kjaergaard AD; Nielsen JS; Rungby J; Brandslund I; Maeng M; Beck-Nielsen H; Vaag A; Sørensen HT; Hansen TK; Thomsen RW
    Diabetes Care; 2023 May; 46(5):1037-1045. PubMed ID: 36930691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
    Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
    J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease.
    Kranenburg G; van der Graaf Y; van der Leeuw J; Nathoe HM; de Borst GJ; Kappelle LJ; Visseren FL; Westerink J;
    Diabetes Care; 2015 Oct; 38(10):1930-6. PubMed ID: 26307606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
    Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary inflammatory index: a potent association with cardiovascular risk factors among patients candidate for coronary artery bypass grafting (CABG) surgery.
    Farhangi MA; Najafi M
    Nutr J; 2018 Feb; 17(1):20. PubMed ID: 29439738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.